Key result
In 921 community-based adults, plasma homocysteine and plasminogen activator inhibitor-1 were positively related to circulating collagen biomarkers.
Why the study?
Are systemic biomarkers representing distinct biological pathways associated with plasma markers of collagen metabolism in a community-based sample?
Cross-Sectional (n=921)
Are systemic biomarkers representing distinct biological pathways associated with plasma markers of collagen metabolism in a community-based sample?
Plasma homocysteine and plasminogen activator inhibitor-1 are positively associated with circulating markers of collagen turnover, supporting their potential role in cardiovascular collagen metabolism and remodeling.
Answers are grounded in this paper and cite their sources.
Association in community adults is hypothesis-generating; leaves open causal roles in cardiac remodeling pending longitudinal data.
OBJECTIVE: Hyperhomocysteinemia, neurohormonal activation, inflammation and altered fibrinolysis have been linked to atherothrombosis as well as to myocardial fibrosis and heart failure. Hence, we related a panel of biomarkers representing these pathways to plasma markers of collagen metabolism in a large community-based sample. METHODS: We related nine biomarkers representing select biologic pathways (independent variables: C-reactive protein, B-type natriuretic peptide, N-terminal proatrial natriuretic peptide, aldosterone, renin, fibrinogen, D-dimer, plasminogen activator inhibitor-1 and homocysteine) to three plasma markers of collagen turnover [dependent variables, separate models for each: aminoterminal propeptide of type III collagen, tissue inhibitor of metalloproteinases-1 and matrix metalloproteinase-9 (present versus absent)] in 921 Framingham Heart study participants (mean age 57 years; 58% women). Participants were separated a priori into those with left ventricular end-diastolic dimensions and wall thickness below sex-specific median values (referent group) and either measure at least 90th sex-specific percentile ('remodeled' group). We used stepwise multivariable regression analysis adjusting for cardiovascular risk factors to relate the panel of systemic biomarkers to the three biomarkers of collagen metabolism. RESULTS: Plasma homocysteine was positively related to all three markers of collagen metabolism in the remodeled group and to aminoterminal propeptide of type III collagen and tissue inhibitor of metalloproteinases-1 in the referent group. Plasminogen activator inhibitor-1 was positively related to aminoterminal propeptide of type III collagen and tissue inhibitor of metalloproteinases-1 in both groups, whereas the natriuretic peptides were associated positively with these collagen markers in the referent group. CONCLUSION: In our large community-based sample, plasma homocysteine and plasminogen activator inhibitor-1 were positively related to circulating collagen biomarkers, consistent with experimental studies implicating these pathways in cardiovascular collagen turnover.
No takes yet. Share an insight, caveat, or question.
Joseph et al. (2009) reported a cross-sectional. Systemic biomarkers (including homocysteine, plasminogen activator inhibitor-1, and natriuretic peptides) was evaluated on Plasma markers of collagen turnover (aminoterminal propeptide of type III collagen, tissue inhibitor of metalloproteinases-1, and matrix metalloproteinase-9). In 921 community-based adults, plasma homocysteine and plasminogen activator inhibitor-1 were positively related to circulating collagen biomarkers.
Synapse has enriched 10 related papers. Consider them for comparative context: